Iloprost modulates the immune response in systemic sclerosis-Reference-Cited by-同舟云学术

Iloprost modulates the immune response in systemic sclerosis

Published:2010-12 Issue:1 Volume:11 Page:
ISSN:1471-2172
Container-title:BMC Immunology
language:en
Short-container-title:BMC Immunol

Author:

D'Amelio Patrizia,Cristofaro Maria A,D'Amico Lucia,Veneziano Luciana,Roato Ilaria,Sassi Francesca,Bisignano Giuseppina,Saracco Marta,Pellerito Raffaele,Patanè Salvatore,Ferracini Riccardo,Pescarmona Gian P,Isaia Giovanni C

Publisher

Springer Science and Business Media LLC

Subject

Immunology

Link

http://link.springer.com/content/pdf/10.1186/1471-2172-11-62.pdf

Reference36 articles.

1. Jimenez SA, Derk CT: Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Intern Med. 2004, 140: 37-50.

2. Hussein MR, Hassan HI, Hofny ER, Elkholy M, Fatehy NA, Abd Elmoniem AE, Ezz El-Din AM, Afifi OA, Rashed HG: Alterations of mononuclear inflammatory cells, CD4/CD8+ T cells, interleukin 1beta, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis. J Clin Pathol. 2005, 58: 178-84. 10.1136/jcp.2004.019224.

3. Kalogerou A, Gelou E, Mountantonakis S, Settas L, Zafiriou E, Sakkas L: Early T cell activation in the skin from patients with systemic sclerosis. Ann Rheum Dis. 2005, 64: 1233-5. 10.1136/ard.2004.027094.

4. Parel Y, Aurrand-Lions M, Scheja A, Dayer JM, Roosnek E, Chizzolini C: Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis. Arthritis Rheum. 2007, 56: 3459-67. 10.1002/art.22927.

5. Gustafsson R, Totterman TH, Klareskog L, Hallgren R: Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis. Ann Rheum Dis. 1990, 49: 40-5. 10.1136/ard.49.1.40.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the incidence of melanoma and non-melanoma skin cancer in patients with systemic lupus erythematosus and systemic sclerosis;Italian Journal of Dermatology and Venereology;2024-07

2. Role of regulatory T cells in pathogenesis and therapeutics of scleroderma (systemic sclerosis);Regulatory T Cells and Autoimmune Diseases;2024

3. The Endothelium and COVID-19: An Increasingly Clear Link Brief Title: Endotheliopathy in COVID-19;International Journal of Molecular Sciences;2022-05-31

4. Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19—Mechanisms and Therapeutic Targets;Oxidative Medicine and Cellular Longevity;2021-08-21

5. Iloprost Attenuates Oxidative Stress-Dependent Activation of Collagen Synthesis Induced by Sera from Scleroderma Patients in Human Pulmonary Microvascular Endothelial Cells;Molecules;2021-08-05